financetom
Business
financetom
/
Business
/
Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing
Dec 16, 2024 1:21 AM

04:02 AM EST, 12/16/2024 (MT Newswires) -- Suma Krishnan, 10% Owner, Director, President, Research & Development, on December 13, 2024, sold 50,000 shares in Krystal Biotech ( KRYS ) for $8,240,023. Following the Form 4 filing with the SEC, Krishnan has control over a total of 3,153,144 shares of the company, with 1,475,882 shares held directly and 1,677,262 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1711279/000129871124000015/xslF345X05/wk-form4_1734132509.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bayer's Monsanto wins reversal of $185 million PCBs verdict in Washington court
Bayer's Monsanto wins reversal of $185 million PCBs verdict in Washington court
May 1, 2024
May 1(Reuters) - A Washington state appeals court on Wednesday overturned a $185 million verdict against Bayer's Monsanto unit over chemical contamination at a Seattle-area school, marking the second big legal win for the company in as many weeks. Monsanto spinoff Pharmacia, which sold now-banned chemicals called polychlorinated biphenyls, was found liable in 2021. Three teachers claimed they suffered brain...
Australia's Meteoric signs preliminary deal with Neo Performance to supply rare earths
Australia's Meteoric signs preliminary deal with Neo Performance to supply rare earths
May 1, 2024
May 2 (Reuters) - Australia's Meteoric Resources will supply 3,000 metric tonnes of rare earth oxide per year to Toronto-listed Neo Performance Materials ( NOPMF ) under a preliminary agreement, the companies said on Thursday. Neo's rare earth separation factory in Estonia is expected to purchase the rare earth oxide from the initial output of Meteoric's Caldeira project in Brazil....
Neurocrine Biosciences' Huntington's disease drug gets FDA approval (April 30)
Neurocrine Biosciences' Huntington's disease drug gets FDA approval (April 30)
May 1, 2024
April 30 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' ( NBIX ) Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tuesday. Huntington's disease is an inherited condition that causes the progressive breakdown of nerve cells in the brain, resulting in a gradual decline...
DBS sees net profit rising this year after Q1 beats forecasts
DBS sees net profit rising this year after Q1 beats forecasts
May 1, 2024
By Yantoultra Ngui SINGAPORE (Reuters) -Singapore's biggest bank DBS Group expects its net profit to grow this year, it said on Thursday, after posting a 15% rise in first quarter net profit that beat expectations, driven by strong total income growth. While geopolitical tensions persist, macroeconomic conditions remain resilient and our franchise is well positioned to capture business opportunities, DBS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved